Clinical Assessment of Sarcopenia and Changes in Body Composition During Neoadjuvant Chemotherapy for Esophageal Cancer
Hiroshi Miyata(Osaka University), Masahiko Yano(Nagoya Sangyo University), Shogo Kobayashi(Osaka Gakuin University), Masayuki Ohue(Hyogo Medical University), Norikatsu Miyoshi(Osaka International Cancer Institute), Hirofumi Akita(The University of Osaka), Yoshitomo Yanagimoto(Osaka International Cancer Institute), Akira Tomokuni(Apple (Israel)), Hidenori Takahashi(Osaka International Cancer Institute), Keijiro Sugimura(Osaka International Cancer Institute), Masayoshi Yasui(Osaka International Cancer Institute), Takeshi Omori(Osaka International Cancer Institute), Yoshiyuki Fujiwara(Tottori University Hospital), Masaaki Motoori(Osaka International Cancer Institute)
Cited by 51
Related Papers
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Genome-wide Expression Analysis of Mouse Liver Reveals CLOCK-regulated Circadian Output Genes
|Journal of Biological Chemistry|2003|347
A novel image‐guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation
|Journal of Surgical Oncology|2009|333
High Incidence of Thrombosis of the Portal Venous System After Laparoscopic Splenectomy
|Annals of Surgery|2005|265
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244